Table 2 Blood glucose control in the two randomized groups

Patients

773

777

Study period, median (IQR), days

2 (2–4)

2 (2–4))

0.7

 Glycemic penalty index (GPI), median (IQR)

17.1 (10.6–26.2)

16.3–18.1

10.8 (6.2–16.1)

10.0–11.5

<0.001

 Blood glucose, mean (SD), mg/dL

119 (21)

118–121

111 (15)

110–112

<0.001

 Minimum blood glucose, mg/dL

21

26

 Maximum blood glucose, mg/dL

428

511

 Hyperglycemic index, median (IQR), mg/dL

8.3 (3.4–16.3)

7.5–8.8

3.5 (1.4–7.0)

3.1–4.0

<0.001

 Time-in-target range, median (IQR), percentage

47.1 (28.1–65.0)

45.7–49.3

67.0 (52.1–80.1)

65.4–68.6

<0.001

 Time to reach target range, median (IQR), h

3.6 (0–9.3)

3.2–4.3

2.2 (0–5.1)

1.8–2.5

<0.001

 Mean of maximum delta glycemia per day, median (IQR), mg/dL

36 (27–52)

35–38

34 (24–46)

32–36

<0.001

  <70 mg/dL, n (%)

173 (22.4)

151–196

149 (19.2)

128 –171

0.1

  <60 mg/dL, n (%)

78 (10.1)

62–95

58 (7.5)

44–73

0.07

  <40 mg/dL, n (%)

9 (1.2)

4–15

7 (0.9)

2–13

0.6

  <70 mg/dL, n (%)

346 (1.8)

311–382

342 (1.5)

306–379

0.02

  <60 mg/dL, n (%)

123 (0.7)

102–145

105 (0.5)

85–125

0.02

  <40 mg/dL, n (%)

9 (0.05)

4–15

9 (0.04)

4–15

0.9

 Sampling interval, mean (SD), h

3.0 (0.8)

2.9–3.0

2.3 (0.5)

2.3–2.3

<0.001